Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Advances in anti-thrombotic therapy].

J Páramo1

  • 1Servicio de Hematología, Clínica Universitaria, Universidad de Navarra, Pamplona, Avda Pío XII, 31008 Pamplona. japaramo@unav.es

Anales Del Sistema Sanitario De Navarra
|July 24, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative analysis of margin status in breast conservation surgery and its correlation with subsequent re-excision findings.

Pathologica·2019
Same author

[Von Willebrand factor as an intermediate between hemostasis and angiogenesis of tumor origin].

Revista de medicina de la Universidad de Navarra·2004
Same author

Smaller is better.

Surgical endoscopy·1998
Same author

Fibrinogen Oviedo I. A new Spanish dysfibrinogenaemia.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·1990
Same author

Portal thrombosis: percutaneous transhepatic treatment with urokinase--a case report.

Gastrointestinal radiology·1989
Same journal

[Subacute meningoencephalitis following intravesical BCG instillation immunotherapy].

Anales del sistema sanitario de Navarra·2026
Same journal

[Treatment with dabrafenib and trametinib in an intrahepatic cholangiocarcinoma harboring a BRAF V600E mutation].

Anales del sistema sanitario de Navarra·2026
Same journal

[Efficiency after integrating a hospital with a 'new management model'].

Anales del sistema sanitario de Navarra·2026
Same journal

[Anales del Sistema Sanitario de Navarra in 2025: Progress continues].

Anales del sistema sanitario de Navarra·2026
Same journal

Qualitative evaluation of a community intervention in educational centres: Opinion of the professionals involved.

Anales del sistema sanitario de Navarra·2026
Same journal

[Unequal impact of COVID-19 on mortality in long-term care homes across health areas of Castilla-La Mancha (Spain)].

Anales del sistema sanitario de Navarra·2026
See all related articles

New antithrombotic agents, including anticoagulants and antiplatelets, are emerging from a better understanding of thrombogenesis. These novel therapies show promise in preventing and treating thrombosis by targeting platelet receptors and vessel wall function.

Area of Science:

  • Pharmacology
  • Biochemistry
  • Vascular Biology

Context:

  • Thrombogenesis mechanisms are increasingly understood.
  • New therapeutic targets for thrombosis have been identified.

Purpose:

  • To review the discovery and development of novel antithrombotic agents.
  • To highlight agents with proven clinical efficacy and those in development.

Summary:

  • Advances in understanding thrombogenesis have spurred the development of anticoagulants, antiplatelets, and fibrinolytics.
  • Low molecular weight heparins, glycoprotein IIb/IIIa inhibitors, and ADP receptor antagonists are clinically effective.
  • Emerging compounds aim to prevent and treat thrombosis by modulating vessel wall function.

Impact:

Related Experiment Videos

  • Provides an overview of the current landscape of antithrombotic therapies.
  • Informs about the potential of new agents in managing thrombotic disorders.
  • Highlights the shift towards targeted therapies for thrombosis.